Titre:
  • Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
Auteur:Perner, Anders; Haase, Nicolai; Guttormsen, Anne B; Tenhunen, Jyrki; Klemenzson, Gudmundur; Åneman, Anders; Madsen, K.; Møller, Morten H; Elkjær, Jeanie M; Poulsen, Lone M; Bendtsen, Asger; Winding, Robert; Steensen, Morten; Berezowicz, Pawel; Søe-Jensen, Peter; Bestle, Morten; Strand, Kristian; Wiis, Jørgen; White, J.O.; Thornberg, Klaus J; Quist, Lars; Nielsen, Jonas; Andersen, Ulrik Lund; Holst, Lars B; Thormar, Katrin; Kjældgaard, Anne-Lene; Fabritius, Maria L; Mondrup, Frederik; Pott, Frank C; Møller, Thea P; Winkel, Per; Wetterslev, Jørn; De Backer, Daniel
Informations sur la publication:The New England journal of medicine, 367, 2, page (124-134)
Statut de publication:Publié, 2012-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Aged
Double-Blind Method
Female
Fluid Therapy -- adverse effects -- methods
Hemorrhage -- chemically induced
Humans
Hydroxyethyl Starch Derivatives -- adverse effects -- therapeutic use
Intention to Treat Analysis
Isotonic Solutions -- adverse effects -- therapeutic use
Kidney Failure, Chronic -- etiology -- therapy
Male
Middle Aged
Renal Replacement Therapy
Sepsis -- complications -- mortality -- therapy
Note générale:Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
6S Trial Group ; Scandinavian Critical Care Trials Group
Langue:Anglais
Identificateurs:urn:issn:0028-4793
info:doi/10.1056/NEJMoa1204242
info:pmid/22738085